Patents by Inventor Jay Shukla
Jay Shukla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12268825Abstract: Ready-to-use (RTU) Sodium Phosphates solutions for phosphorus replacement therapy are presented that include Sodium phosphate with/without sodium chloride at a fixed volume with 6 to 15 mmol/100 mL phosphorus, no more than 20 mEq/100 mL Sodium and less than 25 mcg/L aluminum.Type: GrantFiled: October 14, 2024Date of Patent: April 8, 2025Assignee: Nivagen Pharmaceuticals, Inc.Inventors: Niravbhai Jayantibhai Patel, Brijeshkumar B Pandya, Dasaradhi Lakkaraju, Jay Shukla, Rucha Abhijit Kelekar, Robert Miller, Sunil Dnyanu Khandekar, Sudhir Shantaram Jagdale
-
Publication number: 20240423954Abstract: Compositions of a stabilized chlorthalidone suspension and methods for making a stabilized chlorthalidone suspension include chlorthalidone along with a solubilizing and/or wetting agent, a suspending agent, and a viscosity increasing agent and/or an anti-caking agent, wherein the stabilized chlorthalidone suspension is a uniform dispersion with consistent concentration of chlorthalidone throughout the composition and storage.Type: ApplicationFiled: March 4, 2024Publication date: December 26, 2024Applicant: Nivagen Pharmaceuticals, Inc.Inventors: Govind R. Jagadale, Dasaradhi Lakkaraju, Bala Tripura Sundari Chodavarapu, Niravkumar Prajapati, Anand Shukla, Jay Shukla, Robert Miller, Niravbhai Jayantibhai Patel, Maheshkumar Kalubhai Bhalaria
-
Patent number: 12115187Abstract: Ready-to-use (RTU) Sodium Phosphates solutions for phosphorus replacement therapy are presented that include Sodium phosphate with/without sodium chloride at a fixed volume with 1.5 to 15 mmol/100 mL phosphorus, no more than 20 mEq/100 mL Sodium and less than 50 mcg/L aluminum.Type: GrantFiled: May 17, 2024Date of Patent: October 15, 2024Assignee: Nivagen Pharmaceuticals, Inc.Inventors: Niravbhai Jayantibhai Patel, Robert Miller, Maheshkumar Kalubhai Bhalaria, Rucha Abhijit Kelekar, Brijeshkumar B Pandya, Sunil Dnyanu Khandekar, Sudhir Shantarum Jagdale, Dasaradhi Lakkaraju, Jay Shukla
-
Patent number: 11957658Abstract: Compositions of a stabilized chlorthalidone suspension and methods for making a stabilized chlorthalidone suspension include chlorthalidone along with a solubilizing and/or wetting agent, a suspending agent, and a viscosity increasing agent and/or an anti-caking agent, wherein the stabilized chlorthalidone suspension is a uniform dispersion with consistent concentration of chlorthalidone throughout the composition and storage.Type: GrantFiled: May 26, 2021Date of Patent: April 16, 2024Assignee: Nivagen Pharmaceuticals, Inc.Inventors: Govind R. Jagadale, Dasaradhi Lakkaraju, Bala Tripura Sundari Chodavarapu, Niravkumar Prajapati, Anand Shukla, Jay Shukla
-
Patent number: 11878076Abstract: A composition of, method for producing, and use of an amorphous lyophilized Phenobarbital Sodium having high purity are presented. The amorphous lyophilized Phenobarbital Sodium is storage-stable being essentially void of impurities (e.g., phenylethylacetylurea (PEAU), 2-ethyl-2-phenylmalonamide (2EPMM), and/or alpha-phenylbutyrylguanidine (PBG)) upon reconstitution in water.Type: GrantFiled: January 24, 2023Date of Patent: January 23, 2024Assignee: NIVAGEN PHARMACEUTICALS, INC.Inventors: Bala Tripura Sundari Chodavarapu, Thirupathi Mangali, Jay Shukla, Anand Shukla, Dasaradhi Lakkaraju
-
Patent number: 11672823Abstract: Described is an aqueous calcium gluconate solution formulated without calcium saccharate, which can be stored in a flexible plastic bag and can be terminally sterilized.Type: GrantFiled: July 22, 2022Date of Patent: June 13, 2023Assignee: Nivagen Pharmaceuticals, Inc.Inventors: Thirupathi Mangali, Bala Tripura Sundari Chodavarapu, Anand Shukla, Jay Shukla, Dasaradhi Lakkaraju
-
Publication number: 20230157959Abstract: A composition of, method for producing, and use of an amorphous lyophilized Phenobarbital Sodium having high purity are presented. The amorphous lyophilized Phenobarbital Sodium is storage-stable being essentially void of impurities (e.g., phenylethylacetylurea (PEAU), 2-ethyl-2-phenylmalonamide (2EPMM), and/or alpha-phenylbutyrylguanidine (PBG)) upon reconstitution in water.Type: ApplicationFiled: January 24, 2023Publication date: May 25, 2023Applicant: Nivagen Pharmaceuticals, Inc.Inventors: Bala Tripura Sundari Chodavarapu, Thirupathi Mangali, Jay Shukla, Anand Shukla, Dasaradhi Lakkaraju
-
Publication number: 20230043597Abstract: Described is an aqueous calcium gluconate solution formulated without calcium saccharate, which can be stored in a flexible plastic bag and can be terminally sterilized.Type: ApplicationFiled: July 22, 2022Publication date: February 9, 2023Applicant: Nivagen Pharmaceuticals, Inc.Inventors: Thirupathi Mangali, Bala Tripura Sundari Chodavarapu, Anand Shukla, Jay Shukla, Dasaradhi Lakkaraju
-
Publication number: 20220354794Abstract: A composition of, method for producing, and use of an amorphous lyophilized Phenobarbital Sodium having high purity are presented. The amorphous lyophilized Phenobarbital Sodium is storage-stable being essentially void of impurities (e.g., phenyl ethylacetylurea (PEAU), 2-ethyl-2-phenylmalonamide (2EPMM), and/or alpha-phenylbutyrylguanidine (PBG)) upon reconstitution in water.Type: ApplicationFiled: June 30, 2022Publication date: November 10, 2022Applicant: Nivagen Pharmaceuticals, Inc.Inventors: Bala Tripura Sundari Chodavarapu, Thirupathi Mangali, Jay Shukla, Anand Shukla, Dasaradhi Lakkaraju
-
Patent number: 11406598Abstract: A composition of, method for producing, and use of an amorphous lyophilized Phenobarbital Sodium having high purity are presented. The amorphous lyophilized Phenobarbital Sodium is storage-stable being essentially void of impurities (e.g., phenylethylacetylurea (PEAU), 2-ethyl-2-phenylmalonamide (2EPMM), and/or alpha-phenylbutyrylguanidine (PBG)) upon reconstitution in water.Type: GrantFiled: September 18, 2020Date of Patent: August 9, 2022Assignee: NIVAGEN PHARMACEUTICALS, INC.Inventors: Bala Tripura Sundari Chodavarapu, Thirupathi Mangali, Jay Shukla, Anand Shukla, Dasaradhi Lakkaraju
-
Publication number: 20210369673Abstract: Compositions of a stabilized chlorthalidone suspension and methods for making a stabilized chlorthalidone suspension include chlorthalidone along with a solubilizing and/or wetting agent, a suspending agent, and a viscosity increasing agent and/or an anti-caking agent, wherein the stabilized chlorthalidone suspension is a uniform dispersion with consistent concentration of chlorthalidone throughout the composition and storage.Type: ApplicationFiled: May 26, 2021Publication date: December 2, 2021Applicant: Nivagen Pharmaceuticals, Inc.Inventors: Govind R. Jagadale, Dasaradhi Lakkaraju, Bala Tripura Sundari Chodavarapu, Niravkumar Prajapati, Anand Shukla, Jay Shukla
-
Publication number: 20210085608Abstract: A composition of, method for producing, and use of an amorphous lyophilized Phenobarbital Sodium having high purity are presented. The amorphous lyophilized Phenobarbital Sodium is storage-stable being essentially void of impurities (e.g., phenylethylacetylurea (PEAU), 2-ethyl-2-phenylmalonamide (2EPMM), and/or alpha-phenylbutyrylguanidine (PBG)) upon reconstitution in water.Type: ApplicationFiled: September 18, 2020Publication date: March 25, 2021Applicant: Nivagen Pharmaceuticals, Inc.Inventors: Bala Tripura Sundari Chodavarapu, Thirupathi Mangali, Jay Shukla, Anand Shukla, Dasaradhi Lakkaraju
